High frequency of co-infection by Epstein-Barr virus types 1 and 2 in patients with multiple sclerosis

Multiple Sclerosis Journal

Volumn 17, Issue 11, 2011, Pages 1295-1300

  Santón, Almudena ^a   Cristóbal, Eva ^a   Aparicio, María ^a   Royuela, Ana ^a   Villar, Luisa M ^a   Álvarez Cermeño, José C ^a,b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

Epstein Barr virus; Epstein Barr virus nuclear antigens; multiple sclerosis; viral genome

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN 2;

ADULT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; EPSTEIN BARR VIRUS; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MULTIPLE SCLEROSIS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; VIRUS CHARACTERIZATION; VIRUS DETECTION; VIRUS STRAIN; VIRUS TYPING;

EID: 80655128167     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511411063     Document Type: Article

References (35)

1. Compston A, Coles A. Multiple sclerosis. Lancet. 2008 ; 372: 1502-1517
2. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005 ; 23: 683-747
3. Giovannoni G, Ebers G. Multiple sclerosis: The environment and causation. Curr Opin Neurol. 2007 ; 20: 261-268
4. van der Mei IAF, Ponsonby A-L, Dwyer T, Blizzard L, Simmons R, Taylor BV, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. Br Med J. 2003 ; 327: 316-321
5. Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006 ; 296: 2832-2838
6. Hernán MA, Jick SS, Logroscino G, Olek MJ, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain. 2005 ; 128: 1461-1465
7. Coo H, Aronson KJ. A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology. 2004 ; 23: 1-12
8. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis, part I: The role of infection. Ann Neurol. 2007 ; 61: 288-299
9. Banwell B, Krupp L, Kennedy J, Tellier R, Tenembaum S, Ness J, et al. Clinical features and viral serologies in children with multiple sclerosis: a multinational observational study. Lancet Neurol. 2007 ; 6: 773-781
10. Nielsen TR, Rostgaard K, Nielsen NM, Koch-Henriksen N, Haahr S, Sørensen PS, et al. Multiple sclerosis after infectious mononucleosis. Arch Neurol. 2007 ; 64: 72-75
11. Wandinger KP, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H-J, et al. Association between clinical disease activity and Epstein-Barr virus reactivation in MS. Neurology. 2000 ; 55: 178-184
12. Höllsberg P, Kusk M, Bech E, Hansen HJ, Jakobsen J, Haahr S. Presence of Epstein-Barr virus and human herpesvirus 6B DNA in multiple sclerosis patients: Associations with disease activity. Acta Neurol Scand. 2005 ; 112: 395-402
13. Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, et al. Epstein-Barr virus antibodies and risk of multiple sclerosis. A prospective study. JAMA. 2001 ; 286: 3083-3088
14. Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA. 2005 ; 293: 2496-2500
15. DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A. Epstein-Barr virus and multiple sclerosis. Evidence of association from a prospective study with long-term follow-up. Arch Neurol. 2006 ; 63: 839-844
16. Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, Perkal H, et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol. 2010 ; 67: 159-169
17. Gutiérrez J, Sorlózano A, Soto MJ, Maroto C New Developments in Epstein-Barr Virus Research. Umar CS, ed. New York: Nova Science Publishers Inc. ; 2006: 277-299.
18. Brennan RM, Burrows JM, Bell MJ, Bromham L, Csurhes PA, Lenarczyk A, et al. Strains of Epstein-Barr virus infecting multiple sclerosis patients. Mult Scler. 2010 ; 16: 643-651
19. Rickinson AB, Kieff E Fields Virology. 2, 5th ed.Philadelphia, PA: Lippincott Williams & Wilkins, 2007, pp.2603-2654. Knipe DM Howley PM Griffin DE Lamb RA Martin MA Roizman B Straus SE, ed. Philadelphia, PA: Lippincott Williams & Wilkins ; 2007: 2603-2654.
20. Masjuan J, Álvarez-Cermeño JC, García-Barragán N, Díaz-Sánchez M, Espiño M, Sádaba MC, et al. Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS. Neurology. 2006 ; 66: 576-578
21. Aitken C, Sengupta SK, Aedes C, Moss DJ, Sculley TB. Heterogeneity within the Epstein-Barr virus nuclear antigen 2 gene in different strains of Epstein-Barr virus. J Gen Virol. 1994 ; 75: 95-100
22. Lünemann JD, Münz C. EBV in MS: guilty by association?. Trends Immunol. 2009 ; 30: 243-248
23. Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, et al. An altered immunoresponse to Epstein-Barr virus in multiple sclerosis. Neurology. 2004 ; 62: 2277-2282
24. Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Büssow K, et al. Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Invest. 2005 ; 115: 1352-1360
25. Lünemann JD, Kamradt T, Martin R, Münz C. Epstein-Barr virus: Environmental trigger of multiple sclerosis?. J Virol. 2007 ; 81: 6777-6784
26. Munch M, Hvas J, Christensen T, Møller-Larsen A, Haahr S. A single subtype of Epstein-Barr virus in members of multiple sclerosis clusters. Acta Neurol Scand. 1998 ; 98: 395-399
27. Santón A, Bellas C. Deletions within the Epstein-Barr virus latent membrane protein-1 oncogene in adult ordinary, HIV-associated paediatric Hodgkins disease. Leuk Lymphoma. 2001 ; 40: 235-242
28. Srivastava G, Wong KY, Chiang AKS, Lam KY, Tao Q. Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state. Blood. 2000 ; 95: 2443-2445
29. Lindsey JW, Patel S, Zou J. Epstein-Barr virus genotype in multiple sclerosis. Acta Neurol Scand. 2008 ; 117: 141-144
30. Tierney RJ, Edwards RH, Sitki-Green D, Croom-Carter D, Roy S, Yao QY, et al. Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays. J Infect Dis. 2006 ; 193: 287-297
31. Lucchesi W, Brady G, Dittrich-Breiholz O, Kracht M, Russ R, Farrell PJ. Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. J Virol. 2008 ; 82: 7456-7466
32. Moss DJ, Misko IS, Burrows SR, Burman K, McCarthy R, Sculley TB. Cytotoxic T-cell clones discriminate between A and B-type Epstein-Barr virus transformants. Nature. 1988 ; 331: 719-721
33. Alvarez-Lafuente R, De Las Heras V, Bartolomé M, García-Montojo M, Arroyo R. Human herpesvirus 6 and multiple sclerosis: a one-year follow-up study. Brain Pathol. 2006 ; 16: 20-27
34. Lindsey JW, Hatfield LM, Crawford MP, Patel S. Quantitative PCR for Epstein-Barr virus DNA and RNA in multiple sclerosis. Mult Scler. 2009 ; 15: 153-158
35. Santiago O, Gutierrez J, Sorlozano A, de Dios Luna J, Villegas E, Fernandez O. Relation between Epstein-Barr virus and multiple sclerosis: analytic study of scientific production. Eur J Clin Microbiol Infect Dis. 2010 ; 29: 857-866